Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B Chronic Lymphocytic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00431873
What this trial is testing

A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Mirati Therapeutics Inc. 21
Early research (Phase 1)Study completedNCT02996773
What this trial is testing

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more
University of Arizona 50
Early research (Phase 1)Study completedNCT00003294
What this trial is testing

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT04605666
What this trial is testing

CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Nanfang Hospital, Southern Medical University 77
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT02912754
What this trial is testing

Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Sunnybrook Health Sciences Centre 36
Early research (Phase 1)UnknownNCT03383952
What this trial is testing

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Immune Cell, Inc. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Early research (Phase 1)WithdrawnNCT02657447
What this trial is testing

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Who this might be right for
Non-Hodgkin Lymphoma
Nordic Nanovector
Testing effectiveness (Phase 2)WithdrawnNCT04282174
What this trial is testing

CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

Who this might be right for
Hematologic DiseasesHematologic MalignancyAcute Lymphoblastic Leukemia+3 more
Baptist Health South Florida
Large-scale testing (Phase 3)UnknownNCT01217723
What this trial is testing

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Who this might be right for
Hematologic Malignancies
McMaster University 198
Testing effectiveness (Phase 2)Ended earlyNCT01045382
What this trial is testing

MSC and HSC Coinfusion in Mismatched Minitransplants

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic+6 more
University of Liege 39
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Testing effectiveness (Phase 2)Study completedNCT01414205
What this trial is testing

A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)

Who this might be right for
Lymphocytic Leukemia, Chronic
Genentech, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT03788291
What this trial is testing

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
University of Rochester 39
Early research (Phase 1)Study completedNCT00058227
What this trial is testing

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Testing effectiveness (Phase 2)Study completedNCT01747486
What this trial is testing

Dose Optimization Trial of CD19 Redirected Autologous T Cells

Who this might be right for
Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
University of Pennsylvania 42
Not applicableStudy completedNCT00889031
What this trial is testing

Protocol to Obtain Blood Samples for Leukemia Research

Who this might be right for
Chronic Lymphocytic Leukemia
Dartmouth-Hitchcock Medical Center 187
Next Page
45